Novel bis-indole agents active against multidrug-resistant Acinetobacter baumannii

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 1, 2011, Pages 114-116

  Jacobs, Michael R ^a   Bajaksouzian, Saralee ^a   Good, Caryn E ^a   Butler, Michelle M ^b   Williams, John D ^b   Peet, Norton P ^b   Bowlin, Terry L ^b   Endimiani, Andrea ^c   Bonomo, Robert A ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MICROBIOTIX INC   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Bis indole; In vitro; MBX; Multidrug resistant; Susceptibility

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; DIIMIDAZOLINYLINDOLE DERIVATIVE; IMIPENEM; MBX 1158; MBX 1162; MBX 1196; MBX 1337; MBX 1339; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS;

EID: 78649910297     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.08.014     Document Type: Article

References (8)

1. Butler M.M., Williams J.D., Peet N.P., Moir D.T., Panchal R.G., Bavari S., Bowlin T.L. Novel bis-(imidazolinylindole) antibacterials active against a broad spectrum of bacteria 2008, Abstract F1-3933, ICAAC.
2. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2009, CLSI, Wayne, PA, Approved standard-M7-A8. 8th ed.
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 19th informational supplement 2009, CLSI, Wayne, PA, CLSI document M100-S19.
4. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5:939-951.
5. Hujer K.M., Hujer A.M., Hulten E.A., Bajaksouzian S., Adams J.M., Donskey C.J., Ecker D.J., Massire C., Eshoo M.W., Sampath R., Thomson J.M., Rather P.N., Craft D.W., Fishbain J.T., Ewell A.J., Jacobs M.R., Paterson D.L., Bonomo R.A. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 2006, 50:4114-4123.
6. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N. Engl. J. Med. 2008, 358:1271-1281.
7. Panchal R.G., Ulrich R.L., Lane D., Butler M.M., Houseweart C., Opperman T., Williams J.D., Peet N.P., Moir D.T., Nguyen T., Gussio R., Bowlin T., Bavari S. Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. Antimicrob. Agents Chemother. 2009, 53:4283-4291.
8. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51:3471-3484.